Update on 23andMe and Committee on Energy and Commerce of the United States House of Representatives

As we have previously detailed here in the Spittoon, 23andMe received a letter from the Committee on Energy and Commerce of the United States House of Representatives asking for details of our genetic testing services.  We received a second letter from the Committee asking for more information about the ...

Read more

SNPwatch: Uncertainty Surrounds Longevity GWAS

[Update: This study was formally retracted by Science on July 22, 2011] A genome-wide association study of extreme longevity published last week in the journal Science has been receiving a lot of press attention.  The results are quite extraordinary: the authors identify 70 loci with genome-wide ...

Read more

23andMe Letter to Heads of FDA and NIH

At 23andMe, our goal is to give people the best information possible about their personal genetic data.  We believe that this goal is shared by all genetic testing providers. You may be aware that different personal genetic testing companies, while providing completely accurate test results, may provide ...

Read more

SNPwatch: Genetic Variations Associated with Autoimmune Form of Hair Loss, Alopecia Areata

Alopecia areata is a form of hair loss many people are unfamiliar with, although the condition affects more than five million people in the United States.  Unlike male (or, more rarely, female) pattern baldness, which is thought to be caused by hormones, alopecia areata results from an autoimmune attack on ...

Read more

SNPwatch: Four More DNA Variations Linked to Testicular Cancer

British researchers have identified four new genetic variants that may influence a male's risk for testicular cancer.  These results, published recently in the journal Nature Genetics, along with variations in three genetic regions previously identified by the same group, are beginning to shed some light on ...

Read more

23andMe Publishes in PLoS Genetics, Validates New Research Paradigm

23andMe is proud to announce the first publication to come out of 23andWe, our novel participant-driven research program.  Our results, which encompass replications of previous findings as well as newly discovered associations, appear online today in PLoS Genetics. 23andWe is a web-based research framework ...

Read more

23andMe Improves Research Consent Process

Today, 23andMe is pleased to announce that we have received institutional review board (IRB) approval for our research protocol and an accompanying revised Consent Document.  This approval reaffirms that all 23andMe research efforts intended for publication protect the interests of our customers.  Our ...

Read more

23andMe and a New Paradigm for Research

As highlighted in Thomas Goetz's new Wired article "Sergey's Search," 23andMe's innovative web-based research platform is pushing Parkinson's disease research ahead at an unprecedented pace.  With our database clocking in at 50,000 genotyped customers—a number that grows everyday—we're poised to make exciting ...

Read more

SNPwatch: Genetic Variant Contributing to Melanoma Risk has Different Effects on Mole Count Depending on Age

Melanoma is a rare but deadly form of skin cancer. Known risk factors include pale skin, large numbers of moles (also known as nevi), and prolonged sun exposure. Nevus count has a strong genetic component and researchers have already identified some genetic variants that influence the trait. In a new study ...

Read more

Understanding GINA

The Genetic Information Nondiscrimination Act, or GINA, is U.S. federal legislation that protects Americans from discrimination (in health insurance and employment decisions) on the basis of genetic information. GINA was signed into law by President George W. Bush on May 21, 2008. The Genetic ...

Read more

Return to top